US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist

2.020
+0.060+3.06%

Close Jan 17 16:00 ET

2.030
+0.010+0.50%

Pre 06:58 ET

62.72MMarket Cap-1.03P/E (TTM)

Immuneering Stock Forum

Teddy123

7 hours ago

13G/A filed

$Immuneering (IMRX.US)$

Teddy123

Jan 15 07:14

Near term milestone expectations

$Immuneering (IMRX.US)$
IMM-1-104
Further IMM-1-104 Phase 2a data expected in the second quarter of 2025
Initiation of Phase 2a arms of IMM-1-104 in combination with a BRAF inhibitor, as well as IMM-1-104 in combination with a checkpoint inhibitor, planned for 2025
Immuneering's Cancer Drug Shows 50% Response Rate in Phase 2a Pancreatic Cancer Trial, Beating Benchmark

Teddy123

Jan 13 23:25

8k filed - Recent Development

$Immuneering (IMRX.US)$
On January 13, 2025, Immuneering Corporation (the "Company") announced updated interim response and safety data from the ongoing Phase 2a arm evaluating IMM-1-104 with modified FOLFIRINOX (mFFX) in first-line pancreatic cancer patients, part of the Company's ongoing Phase 1/2a clinical trial of IMM-1-104 in patients with advanced RAS-mutant solid tumors.
The Company announced that, as of January 6, 2025, of the six evaluable patients in the ...

rehabrashwan

Jan 13 08:44

What’s happening?!

$Immuneering (IMRX.US)$
Anyone understands why the stock price keep dropping despite of the positive news?!!!

Teddy123

Jan 13 07:03

Splendid: Clinical Dev Analysis

$Immuneering (IMRX.US)$
The rapid progression of IMM-1-104's development program is noteworthy. Having two parallel first-line pancreatic cancer combination arms showing comparable response rates strengthens the drug's potential positioning. The planned expansion into BRAF inhibitor and checkpoint inhibitor combinations in 2025 suggests a comprehensive development strategy targeting multiple therapeutic approaches.
The Q2 2025 data update will be crucial, as it wil...

Trytosaveabit

Jan 13 07:02

Update

$Immuneering (IMRX.US)$ Reuters· 1 min ago
Immuneering Provides Positive Update on Phase 2a Arm Studying Imm-1-104 in Combination With Modified Folfirinox for First-Line Pancreatic Cancer

Jaguar8

Jan 13 07:01

NEWS

$Immuneering (IMRX.US)$
Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer
Monday, 13th January at 8:00 am
- Two new partial responses (PRs) reported in Phase 2a arm studying IMM-1-104 in combination with modified FOLFIRINOX (mFFX) in first-line pancreatic cancer -
- Overall Response Rate (ORR) of 50%; historic benchmark of 32% for FOLFIRINOX alone -
- Nearly $14M in net proceeds raised in January 20...

Teddy123

Jan 10 06:46

Climb back up pls

$Immuneering (IMRX.US)$

rehabrashwan

Jan 8 17:37

Why keep dropping ?!

$Immuneering (IMRX.US)$
All analysts expecting the stock to raise to minimum $8 and the morningstar evaluation for the stock price is $6, but the stock keep falling dramatically even after the hot news!!
What’s going on? anyone have any idea? or any insights?

72319491 : I have been holding this stock for over 4 months. People love to pump and dump. Nothing to do with the business

Report
Reply

Cancel Reply
Blick : Many pharmaceutical small Stocks are speculations and have nothing to do with actual performance.
This low-active small Stocks can only be bought on dips and held for the long term until the next speculation appears, so please be patient and wait for that day to come.

Report
Reply

Cancel Reply
rehabrashwan OP Blick : Do you have any expectations when it will go up again? on Tuesday there was great news and the stock goes up to $5, then all of a sudden drop in 10 min to $2.36, thats pretty weird, are they short sellers? hedge funds manipulating? Supposedly they recover their short selling soon specially after brokers raised the margin fees from 15% to 99%? Also i wonder why brokers raised the margin fees that much the next day? after that raise they should recover the short selling immediately and not hold it anymore! Don’t you think? I’m too confused!

Report
Reply

Cancel Reply
rehabrashwan OP 72319491 : Why you holding it and what you expecting please ?

Report
Reply

Cancel Reply
Blick rehabrashwan OP : It is not surprising that such small stocks will try to clear all the daily gains before the opening until the opening price, because this is a typical manipulated stock, aiming to trap retail investors' funds at a high level before trading hours.
Although the Pharmaceutical developed by the company is very valuable, their Stocks are not valuable. As for whether it will rise, I think it will, but not in the near future. It may be during the next round of speculation on Pharmaceutical development or cooperation with large companies. It will focus on trading before and after trading hours.
If you are trapped at a high level, you can try to increase your position at a Low Stock Price to lower the average price, waiting for the next sharp rise.

Report
Reply

Cancel Reply